Ernexa Therapeutics Growth Metrics (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Growth Metrics	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)													1.03M	-0.24M
EBITDA Margin Growth (3y) (Quarter)									-1.07M	-1.16M
EBITDA Margin Growth (5y) (Quarter)									-1.08M	-1.18M	-1.23M	-1.05M	-0.05M	-1.42M
EBITDA Margin (QoQ) (Quarter)										-0.10M	-0.05M	0.18M	1.00M	-1.37M
EBIT Margin Growth (1y) (Quarter)													1.03M	-0.24M
EBIT Margin Growth (3y) (Quarter)									-1.07M	-1.16M
EBIT Margin Growth (5y) (Quarter)									-1.08M	-1.18M	-1.23M	-1.05M	-0.05M	-1.42M
EBIT Margin (QoQ) (Quarter)										-0.10M	-0.05M	0.18M	1.00M	-1.37M
EBT Margin Growth (1y) (Quarter)													0.55M	21.67M
EBT Margin Growth (3y) (Quarter)									-1.09M	-1.30M
EBT Margin Growth (5y) (Quarter)									-1.10M	-1.26M	-1.41M	-1.18M	-0.55M	20.41M
EBT Margin (QoQ) (Quarter)										-0.16M	-0.16M	0.24M	0.63M	20.96M
Enterprise Value Growth (1y) (Quarter)	-685.28%	-911.01%	-179.43%	61.31%	45.64%	-15.61%	42.18%	48.33%	3.87%	19.71%	2.07%	-7.47%	66.53%	89.03%	85.59%	59.96%	28.54%	-8.96%	-378.47%	-16.52%
Enterprise Value Growth (3y) (Quarter)	-99.35%	-87.27%	-105.30%	-91.17%	-72.46%	-56.21%	-55.90%	-24.57%	-60.10%	-110.93%	-16.52%	40.11%	44.08%	53.31%	56.62%	39.42%	38.74%	54.22%	12.26%	20.55%
Enterprise Value Growth (5y) (Quarter)	-51.89%	-24.47%	-30.91%	-23.21%	-24.32%	-42.19%	-38.83%	-21.51%	-32.86%	-43.55%	-37.41%	-31.14%	-10.54%	19.61%	11.76%	3.61%	0.38%	-2.32%	-1.76%	36.88%
Enterprise Value (QoQ) (Quarter)	51.39%	30.34%	-38.36%	17.42%	31.71%	-48.15%	30.81%	26.20%	-27.07%	-23.73%	15.60%	19.01%	60.43%	59.45%	-10.93%	-124.97%	29.39%	38.17%	-387.10%	45.35%
FCF Margin Growth (1y) (Quarter)													1.50M	-1.50M
FCF Margin Growth (3y) (Quarter)									-1.60M	-0.35M
FCF Margin Growth (5y) (Quarter)									-1.62M	-0.36M	-0.82M	-0.53M	-0.12M	-1.87M
FCF Margin (QoQ) (Quarter)										1.26M	-0.46M	0.29M	0.41M	-1.74M
FCF Payout Ratio Growth (1y) (Quarter)
FCF Payout Ratio Growth (3y) (Quarter)
FCF Payout Ratio Growth (5y) (Quarter)
Gross Margin Growth (1y) (Quarter)													0.02M	0.01M
Gross Margin Growth (3y) (Quarter)									-0.02M	-0.01M
Gross Margin Growth (5y) (Quarter)									-0.02M	-0.02M	-0.01M	-0.02M	0.00M	-0.00M
Gross Margin (QoQ) (Quarter)										0.00M	0.01M	-0.01M	0.02M	-0.01M
Interest Coverage Ratio Growth (1y) (Quarter)	-22.54%		-343.15%	5.51%	97.23%	110.11%	-2.38%	98.77%	-1,029.64%	-2,352.44%	-237.28%	-3,594.31%	95.17%	100.29%	76.00%	31.77%	-139.97%		-4,100.24%	-188.89%
Interest Coverage Ratio Growth (3y) (Quarter)	-39.46%	-125.89%	-339.01%	-1,478.85%	-91.17%	28.78%	-48.37%	89.85%	27.32%		-148.27%	24.48%	75.27%	26.13%	6.07%	32.24%	-9.38%		-223.96%	-438.60%
Interest Coverage Ratio Growth (5y) (Quarter)	-97.05%	-78.44%	3.33%	-127.55%	-15.91%	24.82%	-2.74%	20.18%	-17.33%	-88.32%	-211.26%	-347.49%	-30.67%	14.97%	-21.46%	51.67%	46.34%		-173.94%	-33.89%
Interest Coverage Ratio (QoQ) (Quarter)	-590.80%	54.25%	89.76%	-191.84%	79.72%	266.73%	-203.77%	96.48%	-18,459.56%	-232.45%	84.46%	61.47%	75.75%	120.10%	-1,377.95%	-9.55%	14.70%	638.26%	-935.08%	17.31%
Net Margin Growth (1y) (Quarter)													0.55M	-1.78M
Net Margin Growth (3y) (Quarter)									-1.08M	-1.24M
Net Margin Growth (5y) (Quarter)									-1.10M	-1.26M	-1.41M	-1.18M	-0.55M	-3.03M
Net Margin (QoQ) (Quarter)										-0.16M	-0.16M	0.24M	0.63M	-2.49M
Operating Margin Growth (1y) (Quarter)													1.03M	-0.24M
Operating Margin Growth (3y) (Quarter)									-1.07M	-1.16M
Operating Margin Growth (5y) (Quarter)									-1.08M	-1.18M	-1.23M	-1.05M	-0.05M	-1.42M
Operating Margin (QoQ) (Quarter)										-0.10M	-0.05M	0.18M	1.00M	-1.37M
Return on Assets Growth (1y) (Quarter)		-4.00	-2.00	-3.00	1.00	4.00	4.00	4.00	1.00	0.00M	-1.00	-1.00	-2.00	0.00M	0.00M	1.00	5.00	-2.00	-1.00	5.00
Return on Assets Growth (3y) (Quarter)			-3.00	-3.00	-1.00	0.00M	0.00M			0.00M	1.00	0.00M	0.00M	4.00	3.00	4.00	5.00	-2.00	-2.00	-1.00
Return on Assets Growth (5y) (Quarter)	-2.00	-3.00	-3.00	-3.00	-1.00	0.00M	0.00M	0.00M			0.00M	0.00M	-2.00	0.00M	0.00M			-2.00	0.00M	-1.00
Return on Assets (QoQ) (Quarter)	-2.00	-1.00	0.00M	0.00M	2.00	1.00	0.00M	0.00M	0.00M	-1.00	0.00M	0.00M	-1.00	2.00	0.00M	0.00M	4.00	-6.00	1.00	0.00M
Return on Capital Employed Growth (1y) (Quarter)		-0.02M	-0.03M	-0.04M	120.00	0.01M	0.01M	0.04M	0.02M	0.02M	0.02M	0.00M	-0.01M	-0.04M	0.03M	-0.02M	-0.01M	0.01M	-0.05M	0.00M
Return on Capital Employed Growth (3y) (Quarter)			-0.04M	-0.05M	-0.02M	-0.02M	-0.02M			0.01M	0.01M	895.00	0.01M	-0.01M	0.06M	0.02M	0.00M	-0.01M	-0.00M	-0.02M
Return on Capital Employed Growth (5y) (Quarter)	-0.02M	-0.03M	-0.03M	-0.05M	-0.02M	-0.02M	-0.02M	-0.01M			-0.01M	-0.01M	-0.01M	-0.04M	0.03M			-0.02M	-0.01M	-0.02M
Return on Capital Employed (QoQ) (Quarter)	-0.02M	-0.01M	-0.00M	-0.01M	0.03M	-0.00M	-447.00	0.01M	0.00M	239.00	-400.00	-525.00	-0.01M	-0.03M	0.07M	-0.05M	0.01M	-0.01M	0.01M	668.00
Return on Invested Capital Growth (1y) (Quarter)	-90.00	0.00M	-53.00				96.00	181.00
Return on Invested Capital Growth (3y) (Quarter)		-92.00	-109.00	-187.00			-11.00		6.00	0.00M									-72.00	-89.00
Return on Invested Capital Growth (5y) (Quarter)	-101.00		-108.00	-187.00			-12.00	-6.00		-8.00							-150.00	0.00M	-29.00
Return on Invested Capital (QoQ) (Quarter)		10.00	-17.00	-79.00				6.00	1.00	-2.00								71.00	6.00	-11.00
Return on Sales Growth (1y) (Quarter)									-104.00	-126.00	-145.00		55.00	0.00M
Return on Sales Growth (3y) (Quarter)					-6.00	0.00M	4.00		-109.00	-130.00
Return on Sales Growth (5y) (Quarter)					-6.00	0.00M	3.00		-110.00	-126.00	-141.00	-118.00	-55.00	0.00M
Return on Sales (QoQ) (Quarter)						6.00	3.00			-16.00	-16.00	24.00	63.00	0.00M

Research Tools

Datasets

Plans

Developers

Ernexa Therapeutics ERNA Growth Metrics (2010-2026)

Research Tools

Datasets

Plans

Developers

Ernexa Therapeutics ERNA Growth Metrics (2010-2026)

Create an account

Sign In

Reset Password